Mohamad Mohty

Professor of Hematology; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.

[Uriel Suárez @UsuarezMD]

IACH News of the Week • 🗞️ Highlights - European Hematology Association Congress 
(EHA 2026; June 11 to 14, Stockholm, Sweden 🇸🇪 ).

@Mohty_EBMT @TheIACH @COMyCongress @EHA_Hematology

https://t.co/TP9RtsnHHH

[IACH @TheIACH]

💡 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴: 𝘉𝘦𝘺𝘰𝘯𝘥 𝘵𝘩𝘦 𝘞𝘦𝘣𝘪𝘯𝘢𝘳

𝗩𝗘𝗫𝗔𝗦 𝗦𝘆𝗻𝗱𝗿𝗼𝗺𝗲: 𝗪𝗵𝗲𝗻 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗕𝗲𝗰𝗼𝗺𝗲𝘀 𝗖𝗹𝗼𝗻𝗮𝗹 𝗛𝗲𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆

🎙️𝘛𝘶𝘯𝘦 𝘪𝘯 𝘵𝘰 𝘢 𝘯𝘦𝘸 𝘱𝘰𝘥𝘤𝘢𝘴𝘵:
https://t.co/dwYsQiK76P

🧑‍💻𝘎𝘢𝘪𝘯 𝘬𝘦𝘺 𝘵𝘢𝘬𝘦𝘢𝘸𝘢𝘺𝘴 𝘧𝘳𝘰𝘮 𝘰𝘶𝘳 𝘫𝘰𝘪𝘯𝘵 𝘐𝘈𝘊𝘙𝘓𝘙𝘋/𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:
https://t.co/SikBgguH50

@Mohty_EBMT

[IACH @TheIACH]

𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 - 𝘈𝘤𝘵𝘶𝘢𝘭𝘪𝘵𝘦́𝘴 𝘥𝘦 𝘭’𝘌𝘏𝘈26

𝗤𝘂𝗼𝗶 𝗱𝗲 𝗻𝗲𝘂𝗳 𝗱𝗮𝗻𝘀 𝗹𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗲?
🗣️𝘋𝘳 𝘈𝘳𝘵𝘩𝘶𝘳 𝘉𝘰𝘣𝘪𝘯

#EHA2026

@Mohty_EBMT @A_Bobin_

[IACH @TheIACH]

🔴𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘜𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:

𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗘𝗕𝗩 𝗿𝗲𝗮𝗰𝘁𝗶𝘃𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗳𝘁𝗲𝗿 𝗛𝗦𝗖𝗧
𝘸𝘪𝘵𝘩 𝘑𝘢𝘯 𝘚𝘵𝘺𝘤𝘻𝘺𝘯𝘴𝘬𝘪

🗓️𝘞𝘦𝘥𝘯𝘦𝘴𝘥𝘢𝘺, 𝘑𝘶𝘭𝘺 1 2026
⏲️6 𝘗𝘔 𝘊𝘌𝘛, 12 𝘗𝘔 𝘕𝘠

𝗥𝗘𝗚𝗜𝗦𝗧𝗘𝗥 𝗙𝗢𝗥 𝗙𝗥𝗘𝗘 👇
https://t.co/1AnaQxbgFr

@Mohty_EBMT

[IACH @TheIACH]

𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 - 𝘈𝘤𝘵𝘶𝘢𝘭𝘪𝘵𝘦́𝘴 𝘥𝘦 𝘭’𝘌𝘏𝘈26

𝗤𝘂𝗼𝗶 𝗱𝗲 𝗻𝗲𝘂𝗳 𝗱𝗮𝗻𝘀 𝗹𝗲 𝗺𝘆𝗲𝗹𝗼𝗺𝗲?
🗣️ 𝘋𝘳 𝘡𝘰𝘧𝘪𝘢 𝘎𝘳𝘰𝘴𝘴

#EHA2026

@Mohty_EBMT

[IACH @TheIACH]

📢𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘

𝘵𝘩𝘦 𝘑𝘰𝘪𝘯𝘵 𝘐𝘈𝘊𝘙𝘓𝘙𝘋/𝘐𝘈𝘊𝘏 𝘸𝘦𝘣𝘪𝘯𝘢𝘳:
𝗩𝗘𝗫𝗔𝗦: 𝗔 𝗺𝗼𝘀𝗮𝗶𝗰 𝗲𝗿𝘆𝘁𝗵𝗿𝗼𝗯𝗹𝗮𝘀𝘁𝗼𝗽𝗲𝗻𝗶𝗮 𝗮𝘁 𝘁𝗵𝗲 𝗰𝗿𝗼𝘀𝘀𝗿𝗼𝗮𝗱 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿
𝘸𝘪𝘵𝘩 𝘈𝘭𝘪 𝘉𝘢𝘻𝘢𝘳𝘣𝘢𝘤𝘩𝘪 𝘢𝘯𝘥 𝘖𝘭𝘪𝘷𝘪𝘦𝘳 𝘏𝘦𝘳𝘮𝘪𝘯𝘦

🎟️ 𝘍𝘙𝘌𝘌 𝘳𝘦𝘨𝘪𝘴𝘵𝘳𝘢𝘵𝘪𝘰𝘯
https://t.co/Qr5gu7vEDR

@Mohty_EBMT

[IACH @TheIACH]

🎓 𝗘𝗮𝗿𝗹𝘆-𝗰𝗮𝗿𝗲𝗲𝗿 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 - 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝗜𝗔𝗖𝗛 𝟮𝟬𝟮𝟲 𝗶𝗻 𝗣𝗮𝗿𝗶𝘀!

IACH is committed to supporting the next generation of hematology professionals through a dedicated Travel Grant & Registration Program for the Annual Meeting.

✨ 𝗪𝗵𝗮𝘁 𝘆𝗼𝘂'𝗹𝗹 𝗿𝗲𝗰𝗲𝗶𝘃𝗲:
• Up to €300 travel support
• Complimentary on-site registration
• Access to cutting-edge science, expert faculty, and a global hematology community

👩‍⚕️ 𝗪𝗵𝗼 𝗰𝗮𝗻 𝗮𝗽𝗽𝗹𝘆?
Residents, Students, Nurses, and Allied Health Professionals under the age of 35.

⏳ Places are limited!

🗓 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗱𝗲𝗮𝗱𝗹𝗶𝗻𝗲: 𝗔𝘂𝗴𝘂𝘀𝘁 𝟭𝟲, 𝟮𝟬𝟮𝟲

𝘈𝘱𝘱𝘭𝘺 𝘩𝘦𝘳𝘦⤵️
https://t.co/YrK4HGsnbc

@Mohty_EBMT

[IACH @TheIACH]

👂𝘛𝘶𝘯𝘦 𝘪𝘯 𝘵𝘰 𝘵𝘩𝘦 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 𝘱𝘰𝘥𝘤𝘢𝘴𝘵 𝘦𝘯𝘵𝘪𝘵𝘭𝘦𝘥:

𝗖𝗮𝗻 𝗮𝗻 𝗔𝗹𝗹-𝗢𝗿𝗮𝗹 𝗖𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗖𝗵𝗮𝗻𝗴𝗲 𝘁𝗵𝗲 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗼𝗳 𝗥𝗲𝗹𝗮𝗽𝘀𝗲𝗱/𝗥𝗲𝗳𝗿𝗮𝗰𝘁𝗼𝗿𝘆 𝗗𝗟𝗕𝗖𝗟?
⬇️⬇️
https://t.co/QYoj9sgaxZ

𝘊𝘭𝘪𝘤𝘬 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘢𝘣𝘴𝘵𝘳𝘢𝘤𝘵👇
https://t.co/Z3XQNwIQRE

@Mohty_EBMT

[IACH @TheIACH]

Last Call for Lymphoma Case Reports!

👉 For more information and submission: https://t.co/782VKwEifA

Deadline is TODAY - June 22, 2026

@Mohty_EBMT @AnnaSureda5 @MKD_BMT @MediHumdani @StefanoLuminari

[IACH @TheIACH]

📣 𝗛𝗔𝗣𝗣𝗘𝗡𝗜𝗡𝗚 𝗧𝗢𝗗𝗔𝗬

𝘑𝘰𝘪𝘯𝘵 𝘐𝘈𝘊𝘙𝘓𝘙𝘋/𝘐𝘈𝘊𝘏 𝘸𝘦𝘣𝘪𝘯𝘢𝘳:
𝗩𝗘𝗫𝗔𝗦: 𝗔 𝗺𝗼𝘀𝗮𝗶𝗰 𝗲𝗿𝘆𝘁𝗵𝗿𝗼𝗯𝗹𝗮𝘀𝘁𝗼𝗽𝗲𝗻𝗶𝗮 𝗮𝘁 𝘁𝗵𝗲 𝗰𝗿𝗼𝘀𝘀𝗿𝗼𝗮𝗱 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿
𝘸𝘪𝘵𝘩 𝘈𝘭𝘪 𝘉𝘢𝘻𝘢𝘳𝘣𝘢𝘤𝘩𝘪 𝘢𝘯𝘥 𝘖𝘭𝘪𝘷𝘪𝘦𝘳 𝘏𝘦𝘳𝘮𝘪𝘯𝘦

🕔 5 𝘗𝘔 𝘊𝘌𝘛, 11 𝘈𝘔 𝘕𝘠

𝗙𝗥𝗘𝗘 𝗥𝗘𝗚𝗜𝗦𝗧𝗥𝗔𝗧𝗜𝗢𝗡⬇️
https://t.co/Qr5gu7vEDR

@Mohty_EBMT

[IACH @TheIACH]

Hematology debates.
Expert insights.
Real-world cases.

Join the 10th Annual Live Medical Crossfire®: Hematologic Malignancies

📍 NYC | July 11–12, 2026

Register → https://t.co/2UhnHZPzpx

@gotoPER

[Vincent Rajkumar @VincentRK]

Just out: Blood Cancer Journal - BCJ Impact factor is now 13.8! @BloodCancerJnl

We are # 3 in Hematology Journals behind only Blood and Lancet Heme. Our goal is to be #1. You can reach me right on here for questions.

BCJ is part of @NaturePortfolio
#Tefferi @n_gangat @mvmateos @SagarLonialMD @Mohty_EBMT
@thanosdimop @DrHKantarjian @szusmani @HadidiSamer
https://t.co/GuWl9ep4ww

[IACH @TheIACH]

💡 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴: 𝘉𝘦𝘺𝘰𝘯𝘥 𝘵𝘩𝘦 𝘞𝘦𝘣𝘪𝘯𝘢𝘳

𝗣𝗼𝘀𝘁-𝗔𝗦𝗖𝗢 𝗮𝗻𝗱 𝗘𝗛𝗔 𝟮𝟬𝟮𝟲: 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 𝗮𝘁 𝘁𝗵𝗲 𝗜𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗿𝗼𝘀𝘀𝗿𝗼𝗮𝗱𝘀

🎙️𝘛𝘶𝘯𝘦 𝘪𝘯 𝘵𝘰 𝘢 𝘯𝘦𝘸 𝘱𝘰𝘥𝘤𝘢𝘴𝘵:
https://t.co/MUZW43b7PW

🧑‍💻𝘎𝘢𝘪𝘯 𝘬𝘦𝘺 𝘵𝘢𝘬𝘦𝘢𝘸𝘢𝘺𝘴 𝘧𝘳𝘰𝘮 𝘰𝘶𝘳 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:
𝗜𝗔𝗖𝗛 𝗣𝗼𝘀𝘁 𝗘𝗛𝗔-𝗔𝗦𝗖𝗢 𝗿𝗼𝘂𝗻𝗱𝘁𝗮𝗯𝗹𝗲

𝘞𝘢𝘵𝘤𝘩 𝘵𝘩𝘦 𝘧𝘶𝘭𝘭 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌🔽
https://t.co/FaX8bYTDiC

@Mohty_EBMT @mvmateos @paurotero @NBahlis

[Uriel Suárez @UsuarezMD]

IACH 🗞️ News of the Week, June 18, 2026 • @Mohty_EBMT @TheIACH

Topics:
- extragastric MALT and H. pylori
- primary CNS lymphoma
- AML
- Myeloma
- defining lines of therapy in hematological malignancies

https://t.co/TP9RtsnHHH

[IACH @TheIACH]

🌐𝘔𝘪𝘴𝘴𝘦𝘥 𝘵𝘩𝘦 𝘭𝘪𝘷𝘦 𝘸𝘦𝘣𝘪𝘯𝘢𝘳?

𝘑𝘰𝘪𝘯 𝙄𝘼𝘾𝙃 𝘼𝙧𝙤𝙪𝙣𝙙 𝙩𝙝𝙚 𝙂𝙡𝙤𝙗𝙚 𝘢𝘯𝘥 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘩𝘦 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝘢𝘵 𝘢 𝘵𝘪𝘮𝘦 𝘤𝘰𝘯𝘷𝘦𝘯𝘪𝘦𝘯𝘵 𝘧𝘰𝘳 𝘺𝘰𝘶𝘳 𝘳𝘦𝘨𝘪𝘰𝘯

𝘵𝘩𝘦 𝘐𝘈𝘊𝘏 𝘛𝘳𝘢𝘯𝘴𝘱𝘭𝘢𝘯𝘵 𝘈𝘤𝘢𝘥𝘦𝘮𝘺 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:
𝗛𝗟𝗔 𝗺𝗮𝘁𝗰𝗵𝗶𝗻𝗴 𝗶𝗻 𝗛𝗖𝗧: 𝗻𝗲𝘄 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗘𝗕𝗠𝗧
𝘸𝘪𝘵𝘩 𝘈𝘯𝘯𝘢𝘭𝘪𝘴𝘢 𝘙𝘶𝘨𝘨𝘦𝘳𝘪

🗓️ 𝘛𝘶𝘦𝘴𝘥𝘢𝘺, 𝘑𝘶𝘯𝘦 23 2026
🕕 7:00𝘱𝘮 𝘉𝘦𝘪𝘫𝘪𝘯𝘨, 𝘏𝘰𝘯𝘨 𝘒𝘰𝘯𝘨
🕘9:00𝘱𝘮 𝘚𝘺𝘥𝘯𝘦𝘺

🎟️𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲
https://t.co/Sfmo9f9dES

@Mohty_EBMT @AnnalisaRugger1

[IACH @TheIACH]

📢𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘

𝗢𝗽𝘁𝗶𝗺𝗮𝗹 𝗠𝗮𝗻𝗮𝗴𝗺𝗲𝗻𝘁𝘀 𝗼𝗳 𝗼𝘁𝗵𝗲𝗿 𝗧𝗼𝘅𝗶𝗰𝗶𝘁𝗶𝗲𝘀 𝗕𝗲𝘆𝗼𝗻𝗱 𝗖𝗥𝗦 𝗮𝗻𝗱 𝗜𝗖𝗔𝗡𝘀 𝘄𝗶𝘁𝗵 𝗖𝗔𝗥 𝗧 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆
𝘸𝘪𝘵𝘩 𝘗𝘢𝘶𝘭𝘢 𝘙𝘰𝘥𝘳𝘪́𝘨𝘶𝘦𝘻 𝘖𝘵𝘦𝘳𝘰

🎟️ 𝘍𝘙𝘌𝘌 𝘳𝘦𝘨𝘪𝘴𝘵𝘳𝘢𝘵𝘪𝘰𝘯
https://t.co/fo8msJXGM4

@Mohty_EBMT
@paurotero

[VJHemOnc @VJHemOnc]

The isatuximab on-body injector is likely to improve #myeloma care by decreasing administration-related toxicity, reducing the logistical burden of treatment, & lowering financial costs.🩸

Find out more in our interview with Xavier Leleu from #EHA2026:

�� 👉 https://t.co/FCmRfnOrN5

#MMSM #MultipleMyeloma #ImmunoOnc #HemOnc

[Simon C @scserendipity1]

A great organisation who were are proud to have started working with
@OpenMedInsights

Mohamad, Amnon and the team could not be more engaging or collegiate.

Inspiring work to really improve patient care globally

@VincentRK @RahulBanerjeeMD @Dr_AmerZeidan @sanamloghavi and many more doing such great work….

[IACH @TheIACH]

📣𝘖𝘶𝘳 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘛𝘳𝘢𝘯𝘴𝘱𝘭𝘢𝘯𝘵 𝘈𝘤𝘢𝘥𝘦𝘮𝘺 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:

𝗛𝗟𝗔 𝗺𝗮𝘁𝗰𝗵𝗶𝗻𝗴 𝗶𝗻 𝗛𝗖𝗧: 𝗻𝗲𝘄 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗘𝗕𝗠𝗧
𝘸𝘪𝘵𝘩 𝘈𝘯𝘯𝘢𝘭𝘪𝘴𝘢 𝘙𝘶𝘨𝘨𝘦𝘳𝘪

📽️𝘕𝘰𝘸 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘰𝘯 𝘥𝘦𝘮𝘢𝘯𝘥

𝘞𝘢𝘵𝘤𝘩 𝘵𝘩𝘦 𝘧𝘶𝘭𝘭 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝘧𝘰𝘳 𝗙𝗥𝗘𝗘⬇️
https://t.co/OXipluI8IW

@Mohty_EBMT @AnnalisaRugger1

[COMy @COMyCongress]

✨𝘏𝘪𝘨𝘩𝘭𝘪𝘨𝘩𝘵𝘴 𝘧𝘳𝘰𝘮 𝘵𝘩𝘦 𝘦𝘹𝘱𝘦𝘳𝘵𝘴

𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 #𝗖𝗢𝗠𝘆𝟮𝟬𝟮𝟲 𝗮𝗻𝗱 𝗸𝗲�� 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗺𝘆𝗲𝗹𝗼𝗺𝗮: 𝘁𝗵𝗲 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮𝗻 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲

Prof. Joy Ho reflects on the key highlights from COMy 2026 and the emerging advances transforming myeloma care

@Mohty_EBMT